| For: | Huang BJ, Guo S, Lin XY, Li YH, Ma HM, Zhang J, Chen QL. Oral Akkermansia muciniphila may ameliorates immune dysregulation in a murine model of streptozotocin-induced type 1 diabetes. World J Diabetes 2025; 16(12): 111771 [PMID: 41480616 DOI: 10.4239/wjd.v16.i12.111771] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i12/111771.htm |
| Number | Citing Articles |
| 1 |
Yi-Yuan Zheng, Xing-Li Wu, Jun-Min Wang, Jun Xu, Ying Qian. Letter to the Editor: <i>Akkermansia muciniphila</i> serves as an immunomodulator for type 1 diabetes mellitus: Promises and pitfalls. World Journal of Diabetes 2026; 17(6): 117542 doi: 10.4239/wjd.117542
|
| 2 |
Emre Adıgüzel, Beyzanur Bağçovan, Nuh Mehmet Bozkurt, Gökhan Ünal, Napoleon Waszkiewicz. Intermittent Fasting and Akkermansia muciniphila Exert Independent and Combined Benefits on Behavioral and Neurobiological Deficits in a VPA-Induced Autism Rat Model. Nutrients 2026; 18(5) doi: 10.3390/nu18050777
|